Industries > Pharma > Clinical Trial Supply and Logistics Market for Pharma 2020-2030

Clinical Trial Supply and Logistics Market for Pharma 2020-2030

Forecasts by Type (Clinical Trial Manufacturing (Clinical Trial Packaging, Others), Clinical Trial Logistics and Distribution (Clinical Trial Cold Chain Logistics, Others), Clinical Trial Supply Chain Management), by End Users (CRO’s, Pharma & Biotech, Others (Academics, Research Institutes etc.)) PLUS COVID-19 Impact Analysis, and leading companies analysis in the Clinical Trial Supply and Logistics Market

PUBLISHED: 24 April 2020
PAGES: 306
PRODUCT CODE: PHA0736

Clear
WOOCS 2.2.1

The global clinical trials supply and logistics market for pharma is estimated to have reach $10.3bn in 2019, dominated by the clinical trial manufacturing segment. The global clinical trial supply and logistics market for pharma is expected to grow at a CAGR of 6.6% in the first half of the forecast period. This new report also covers the economic impact of COVID-19 as well as how the pandemic will affect your industry sector.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 306-page report you will receive 90 charts– all unavailable elsewhere.

The 306-page report provides clear detailed insight into the global clinical trial supply and logistics market for pharma. Discover the key drivers and challenges affecting the market.

The report also includes insight on how COVID-19 will affect your industry.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2020 to 2030 for the global clinical trial supply and logistics market. This report also discusses the Drivers and Restraints of the global clinical trial supply and logistics market.

• Revenue and growth forecasts from 2020 to 2030 for the leading submarkets of the global clinical trial supply and logistics market:

• Manufacturing – also with sub forecasting for packaging and for other production

Logistics and distribution – also with sub forecasts for cold chain logistics and for other services

Supply chain management

Clinical Trial Supply and Logistics Market for Pharma 2020-2030

This report discusses the Drivers and Restraints of each submarket.

• Revenue and growth forecasts from 2019 to 2029 for the leading national markets:
• United States
• Japan
• EU5: Germany, France, United Kingdom, Italy, Spain
• Brazil
• Mexico
• China
• India
• GCC
• South Africa
• Rest of the World

Revenues forecast for the US, Japan, EU5, Brazil, Mexico, China, India, GCC, South Africa are further broken down by submarket.

• This report profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry:
• ADAllen Pharma
• Almac Group
• Amatsigroup
• Catalent
• DHL
• FedEx
• Fisher Clinical Services
• Marken
• Parexel International
• Sharp Packaging Services, LLC
• Many others

• This report provides qualitative analysis of the clinical trial supply and logistics market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the clinical trial supply and logistics market. Social, Technological, Economic and Political factors that influence this market are also discussed.

• This report discusses trends in the clinical trial supply and logistics market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management.

• This report discusses the regulatory outlook of the clinical trial supply and logistics industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials

• Key Questions Answered by this Report:
• How is the clinical trial supply and logistics market for pharma evolving?
• What are the drivers and restraints for the growth of the clinical trial supply and logistics market for pharma?
• How will each clinical trial supply and logistics submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each clinical trial supply and logistics submarket for pharma develop to 2030?
• What is the value of the leading clinical trial supply and logistics submarket for pharma s in important regions of the world?
• What will be the main driver for the overall market to 2030?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market by 2030?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market for pharma. You find data, trends and predictions.

Buy our report today Clinical Trial Supply and Logistics Market for Pharma: Forecasts by Type (Clinical Trial Manufacturing (Clinical Trial Packaging, Others), Clinical Trial Logistics and Distribution (Clinical Trial Cold Chain Logistics, Others), Clinical Trial Supply Chain Management), by End Users (CRO’s, Pharma & Biotech, Others (Academics, Research Institutes etc.)) PLUS COVID-19 Impact Analysis.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Clinical Trial Supply and Logistics Market for Pharma 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Clinical Trial Supply and Logistics Market for Pharma 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category